The good and the bad
What the neighbors say
Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo
A critical appraisal of point-of-care coagulation testing in critically ill patients
Stroke in atrial fibrillation and improving the identification of ‘high-risk’ patients: the crossroads of immunity and thrombosis
Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity
Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register
Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials
Coagulation indices in very preterm infants from cord blood and postnatal samples
Complexity and diversity of F8 genetic variations in the 1000 genomes
Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive
Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13
Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13
Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders
Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides
Leukemia-associated Rho guanine-nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice
Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis?: comment
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: reply
It's time to renew your membership in the ISTH, the Leading Global Community of Specialists in Thrombosis and Hemostasis